Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Vincent T. Ma"'
Autor:
Myiah Quach, BS, John P. Antonelli, BS, Charlotte LaSenna, MD, Mackenzie Asel, MD, Jennifer Pleva, DNP, Vincent T. Ma, MD
Publikováno v:
JAAD Case Reports, Vol 45, Iss , Pp 91-93 (2024)
Externí odkaz:
https://doaj.org/article/165edcd3768d4ddaa3452a1b0ed664f7
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Management of cutaneous malignancies can be particularly challenging when they are located in the periocular region. The standard of care for localized disease is complete surgical excision, but this may not be possible without significant disruption
Externí odkaz:
https://doaj.org/article/056051d286024f5dad8deaf865f2ea0f
Autor:
Vincent T. Ma, Alahendra A. Chamila Perera, Yilun Sun, Merna Sitto, Jessica J. Waninger, Govind Warrier, Michael D. Green, Leslie A. Fecher, Christopher D. Lao
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundStandard combination ipilimumab/nivolumab (I/N) is given as 4 induction doses for advanced stage melanoma followed by nivolumab single-agent maintenance therapy. While many patients receive less than 4 doses due to immune-related toxicities
Externí odkaz:
https://doaj.org/article/24f277d92c434e08b89fee9a38e49630
Autor:
Vincent T. Ma, Charles S. Katzman, Phillip L. Palmbos, Rajiv M. Patel, Johann E. Gudjonsson, Ajjai S. Alva
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 1, Iss , Pp 100004- (2020)
Immune-mediated cutaneous reactions are a frequent occurrence in cancer patients treated with immune checkpoint inhibitors. A small subset of these adverse events are psoriasiform reactions. To date, there is no high-level evidence supporting the mos
Externí odkaz:
https://doaj.org/article/b542242dacf0436baa4cc6c44c36c7f7
Publikováno v:
Immunotherapy
Immune-related adverse events (irAEs) are a major concern when treating cancer patients with immune checkpoint inhibitor (ICI) therapy. Selecting the most appropriate management of irAEs remains an ongoing challenge because prolonged use of glucocort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6235dc352e8020cd74796b7f622dae7c
https://doi.org/10.2217/imt-2021-0274
https://doi.org/10.2217/imt-2021-0274
Autor:
Paul W. Harms, Scott A. Tomlins, Christopher K. Bichakjian, Tasha M. Hughes, Scott A. McLean, Steven Hrycaj, Vincent T. Ma, Javed Siddiqui, Rajiv M. Patel, Douglas R. Fullen, May P. Chan, Jae Eun Choi, Josh N. Vo, Rahul Mannan, Daniel R. Rhodes, Nallasivam Palanisamy, Shannon Carskadon, Xiaoming Wang, Bryan Johnson, Lili Zhao, Kelly L. Harms
Supplementary Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c29bbbf8c271f15cb6d4040271aa104
https://doi.org/10.1158/1078-0432.22482855.v1
https://doi.org/10.1158/1078-0432.22482855.v1
Autor:
Paul W. Harms, Scott A. Tomlins, Christopher K. Bichakjian, Tasha M. Hughes, Scott A. McLean, Steven Hrycaj, Vincent T. Ma, Javed Siddiqui, Rajiv M. Patel, Douglas R. Fullen, May P. Chan, Jae Eun Choi, Josh N. Vo, Rahul Mannan, Daniel R. Rhodes, Nallasivam Palanisamy, Shannon Carskadon, Xiaoming Wang, Bryan Johnson, Lili Zhao, Kelly L. Harms
Supplementary Figures S1-S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44459818efccaa1f317d4168e7b73fa
https://doi.org/10.1158/1078-0432.22482849
https://doi.org/10.1158/1078-0432.22482849
Autor:
Paul W. Harms, Scott A. Tomlins, Christopher K. Bichakjian, Tasha M. Hughes, Scott A. McLean, Steven Hrycaj, Vincent T. Ma, Javed Siddiqui, Rajiv M. Patel, Douglas R. Fullen, May P. Chan, Jae Eun Choi, Josh N. Vo, Rahul Mannan, Daniel R. Rhodes, Nallasivam Palanisamy, Shannon Carskadon, Xiaoming Wang, Bryan Johnson, Lili Zhao, Kelly L. Harms
Purpose:Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma that can be divided into two classes: virus-positive (VP) MCC, associated with oncogenic Merkel cell polyomavirus (MCPyV); and virus-negative (VN) MCC, associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a1b72194a2bd3b395c49842ab05425
https://doi.org/10.1158/1078-0432.c.6531015
https://doi.org/10.1158/1078-0432.c.6531015
Autor:
Monique Verhaegen, Arul M. Chinnaiyan, Julia VanGoor, Drew Pratt, Doris Mangelberger, Xuhong Cao, Fengyun Su, Andrzej A. Dlugosz, Jean C. Tien, Josh N. Vo, Jae Eun Choi, Paul W. Harms, Vincent T. Ma, Saravana M. Dhanasekaran
Publikováno v:
J Invest Dermatol
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma that is classified as Merkel cell polyomavirus (MCPyV)-positive or virus-negative. Epigenetic changes, such as DNA methylation, can alter gene expression and influence ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9800e157da2714c36f820ce0d3c4a517
https://doi.org/10.1016/j.jid.2021.07.173
https://doi.org/10.1016/j.jid.2021.07.173